atezolizumab,talazoparib
roche,pfizer
['atezo', 'talazo', 'sclc']
the #oncoalerttoptweet day 2 #asco23 tweet by faculty phase 2 on maintenance talazoparib in slfn11+ es-sclc having atezo. 79%+ (any staining). n=106 randomized. pfs modestly sign improved but not os. best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨